Literature DB >> 11559433

Regulation of interleukin-8 expression by tumor-associated stress factors.

Q Shi1, Q Xiong, X Le, K Xie.   

Abstract

Tumor and host cells frequently express interleukin-8 (IL-8). IL-8 has been shown to be motogenic, mitogenic, and angiogenic and to play important roles in human tumor progression. IL-8 expression can be induced by numerous stress factors present in the tumor environment, such as hypoxia, acidosis, hyperglycemia, hyperosmotic pressure, high cell density, hyperthermia, radiation, and chemotherapeutic agents. Understanding the mechanisms of IL-8 expression and regulation will be helpful in designing potential therapeutic modalities targeting IL-8 to control tumor growth and metastasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559433     DOI: 10.1089/10799900152547812

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  21 in total

1.  Senescent Breast Luminal Cells Promote Carcinogenesis through Interleukin-8-Dependent Activation of Stromal Fibroblasts.

Authors:  Huda H Al-Khalaf; Hazem Ghebeh; Rabia Inass; Abdelilah Aboussekhra
Journal:  Mol Cell Biol       Date:  2019-01-03       Impact factor: 4.272

2.  Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway.

Authors:  C Visciano; F Liotti; N Prevete; G Cali'; R Franco; F Collina; A de Paulis; G Marone; M Santoro; R M Melillo
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867

3.  Toward an integrative analysis of the tumor microenvironment in ovarian epithelial carcinoma.

Authors:  Ryan N Serio
Journal:  Cancer Microenviron       Date:  2011-11-23

4.  Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinoma.

Authors:  Liz Y Han; Charles N Landen; Jose G Trevino; Jyotsnabaran Halder; Yvonne G Lin; Aparna A Kamat; Tae-Jin Kim; William M Merritt; Robert L Coleman; David M Gershenson; William C Shakespeare; Yihan Wang; Raji Sundaramoorth; Chester A Metcalf; David C Dalgarno; Tomi K Sawyer; Gary E Gallick; Anil K Sood
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

5.  Interleukin-8 Dedifferentiates Primary Human Luminal Cells to Multipotent Stem Cells.

Authors:  Huda H Al-Khalaf; Hazem Ghebeh; Salma M Wakil; Falah Al-Mohanna; Abdelilah Aboussekhra
Journal:  Mol Cell Biol       Date:  2020-04-13       Impact factor: 4.272

6.  Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer.

Authors:  Claudia Rubie; Vilma Oliveira Frick; Sandra Pfeil; Mathias Wagner; Otto Kollmar; Berit Kopp; Stefan Graber; Bettina M Rau; Martin K Schilling
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

7.  Modulation of cytokine-induced production of IL-8 in vitro by interferons and glucocorticosteroids.

Authors:  Kristina Nyhlén; Chamilly Gautam; Rolf Andersson; Uppugunduri Srinivas
Journal:  Inflammation       Date:  2004-04       Impact factor: 4.092

8.  Metadherin contributes to epithelial-mesenchymal transition and paclitaxel resistance induced by acidic extracellular pH in nasopharyngeal carcinoma.

Authors:  Changyun Yu; Yong Liu; Zhaobing Qin
Journal:  Oncol Lett       Date:  2018-01-10       Impact factor: 2.967

9.  CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation.

Authors:  Claudia R Amura; Kelley S Brodsky; Berenice Gitomer; Kim McFann; Gwendal Lazennec; Matthew T Nichols; Alkesh Jani; Robert W Schrier; R Brian Doctor
Journal:  Am J Physiol Cell Physiol       Date:  2008-01-16       Impact factor: 4.249

10.  Selective upregulation of interleukin-8 by human rhabdomyosarcomas in response to hypoxia: therapeutic implications.

Authors:  Marcin Wysoczynski; Dong-Myung Shin; Magda Kucia; Mariusz Z Ratajczak
Journal:  Int J Cancer       Date:  2010-01-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.